ZBIO vs MBX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

ZBIO

67.3
AI Score
VS
ZBIO Wins

MBX

57.4
AI Score

Investment Advisor Scores

ZBIO

67score
Recommendation
BUY

MBX

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZBIO MBX Winner
Net Income -377.74M -60.61M MBX
Operating Income -383.06M -68.20M MBX
ROE -156.0% -14.8% MBX
ROA -98.5% -13.9% MBX
Total Assets 383.64M 435.91M MBX
Cash 110.64M 54.12M ZBIO
Current Ratio 5.61 18.08 MBX
Free Cash Flow -172.35M -44.17M MBX

Relative Price Performance (Last 90 Days)

ZBIO 1M: -14.6% · 3M: +7.0% MBX 1M: -3.9% · 3M: +1.4%

Current Technical Phase

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.9 · Price: $28.30

MBX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.3 · Price: $58.51

Fundamentals Snapshot

Metric ZBIO MBX
Market Cap — —
Forward P/E -6.1 -14.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin -212.5% —
Operating Margin -77.7% 0.0%
EPS -10.00 -2.28
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.